Balance Sheet
Accounts PayablesAccumulated ExpensesCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent TaxesGoodwill & IntangiblesInventoryLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zhengye Biotechnology Holding (ZYBT) Receivables - Other: 2023-2024

  • Zhengye Biotechnology Holding's Receivables - Other rose 99.08% to $360,000 in Q4 2024 from the same period last year, while for Dec 2024 it was $360,000, marking a year-over-year increase of 99.08%. This contributed to the annual value of $365,462 for FY2024, which is 98.37% up from last year.
  • Latest data reveals that Zhengye Biotechnology Holding reported Receivables - Other of $360,000 as of Q4 2024, which was up 99.08% from $180,831 recorded in Q4 2023.
  • Zhengye Biotechnology Holding's Receivables - Other's 5-year high stood at $360,000 during Q4 2024, with a 5-year trough of $180,831 in Q4 2023.
  • In the last 2 years, Zhengye Biotechnology Holding's Receivables - Other had a median value of $270,416 in 2023 and averaged $270,416.
  • Data for Zhengye Biotechnology Holding's Receivables - Other shows a peak YoY skyrocketed of 99.08% (in 2024) over the last 5 years.
  • Zhengye Biotechnology Holding's Receivables - Other (Quarterly) stood at $180,831 in 2023, then surged by 99.08% to $360,000 in 2024.